Forbes July 2, 2024
Topline
Moderna has secured $176 million in federal funding to develop mRNA vaccines against a potential bird flu pandemic, the Boston-based company announced Tuesday, a move that could bolster U.S. vaccine stockpiles as health officials and experts worry the highly contagious H5N1 influenza virus tearing through poultry farms and cattle herds could spread to humans .
Key Facts
Crucial Quote
Moderna CEO Stéphane Bancel said “mRNA vaccine technology offers advantages in efficacy, speed of development, and production scalability and reliability in addressing infectious disease outbreaks,” all of which were demonstrated during their rapid development and rollout during the COVID-19 pandemic, when Moderna also received Barda funding. “We are pleased to continue our collaboration with Barda to expedite our development efforts...
Today's Sponsors
Today's Sponsor